Alexithymia in patients with type 2 diabetes mellitus: the role of anxiety, depression, and glycemic control
Authors Avci D, Kelleci M
Received 19 April 2016
Accepted for publication 21 June 2016
Published 20 July 2016 Volume 2016:10 Pages 1271—1277
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 4
Editor who approved publication: Dr Johnny Chen
Dilek Avci,1 Meral Kelleci2
1Department of Nursing, Faculty of Health Sciences, Bandirma Onyedi Eylul University, Balikesir, 2Department of Nursing, Faculty of Health Sciences, Cumhuriyet University, Sivas, Turkey
Objective: This study was aimed at determining the prevalence of alexithymia in patients with type 2 DM and the factors affecting it.
Methods: This cross-sectional study was conducted with 326 patients with type 2 DM. Study data were collected with the Personal Information Form, Toronto Alexithymia Scale, and Hospital Anxiety and Depression Scale. Glycemic control was assessed by glycated haemoglobin (HbA1c) results. The analysis was performed using descriptive statistics, chi-square test, Pearson’s correlation, and logistic regression analysis.
Results: Of the patients, 37.7% were determined to have alexithymia. A significant relationship was determined between alexithymia and HbA1c, depression, and anxiety. According to binary logistic regression analyses, alexithymia was 2.63 times higher among those who were in a paid employment than those who were not, 2.09 times higher among those whose HbA1c levels were ≥7.0% than those whose HbA1c levels were <7.0%, 3.77 times higher among those whose anxiety subscale scores were ≥11 than those whose anxiety subscale scores were ≤10, and 2.57 times higher among those whose depression subscale scores were ≥8 than those whose depression subscale scores were ≤7.
Conclusion: In this study, it was determined that two out of every five patients with DM had alexithymia. Therefore, their treatment should be arranged to include mental health care services.
Keywords: diabetes mellitus, alexithymia, mental symptoms, HbA1c
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]